Picture of Anest Iwata logo

6381 Anest Iwata Income Statement

0.000.00%
jp flag iconLast trade - 00:00
IndustrialsBalancedSmall CapSuper Stock

Annual income statement for Anest Iwata, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue38,80739,09135,58942,33748,515
Cost of Revenue
Gross Profit16,77716,58614,92618,22821,337
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses34,56135,45832,28037,60242,637
Operating Profit4,2463,6333,3084,7355,878
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes4,5804,2134,1375,5427,091
Provision for Income Taxes
Net Income After Taxes3,3443,0483,0444,1495,270
Minority Interest
Net Income Before Extraordinary Items
Net Income2,9482,7182,6233,5414,382
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income2,9482,7182,6233,5414,382
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS79.274.970.693.3114
Dividends per Share